Yehia Ibrahim Abugabal - University of Texas MD Anderson Cancer Center

基本信息

Career Trajectory

Bio

Yehia Abugabal currently works at MD Anderson Cancer Center, University of Texas . Abugabal research area of interest is breast and GI malignancies.

Research Interests

Papers共 33 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

A Meta-Analysis and Real-World Cohort Study on the Sex-Related Differences in Efficacy and Safety of Immunotherapy for Hepatocellular Carcinoma

JHEP reports innovation in hepatologyno. 2 (2023): 100982-100982

Cited0Views0WOSBibtex

Efficacy and Tolerability of Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma Previously Treated with Systemic Therapy: a Global, Observational Study

Vincent Joerg,Bernhard Scheiner,Antonio D'Alessio,Claudia Fulgenzi,Martin Schoenlein,Lorenz Kocheise,Ansgar W. Lohse,Samuel Huber,Henning Wege,Ahmed Kaseb,Yinghong Wang,Mahvish Muzaffar,Yehia Abugabal,Shadi Chamseddine,Samuel Phen,Jaekyung Cheon,Pei-Chang Lee,Lorenz Balcar,Anja Krall,Celina Ang, Linda Wu, Anwaar Saeed, Yi-Hsiang Huang,Bertram Bengsch,Lorenza Rimassa,Arndt Weinmann, Rudolf E. Stauber,James Korolewicz, Matthias Pinter, Amit Singal, Hong Jae Chon, David J. Pinato,Kornelius Schulze, Johann von Felden

Journal of hepatology (2023): S582-S582

Cited0Views0Bibtex

Translational Analysis of Combination of 5-Fluorouracil (FU), Interferon (Ifn)-Alpha2, and Nivolumab in Unresectable Fibrolamellar Liver Cancer

Sunyoung S. Lee,Fei Duan,Shadi Chamseddine,Sonali Jindal,Sreyashi Basu,Shalini Yadav,James Allison,Padmanee Sharma,Yehia I. Abugabal,Ahmed Omar Kaseb

JOURNAL OF CLINICAL ONCOLOGY（2023）

Cited0Views0Bibtex

European journal of cancer (2021): 140-152

Cited41Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn